Richard Shannon


Richard studied Chemistry at the University of Sheffield and stayed on to complete a PhD studying Functional Supramolecular Assemblies. His first industry position was in the Analytical Department at Pfizer, based in Sandwich, where he worked mainly on HPLC analysis of small molecules. He then took up a position at the MRC Mitochondrial Biology Unit in Cambridge and worked on the isolation, purification and analysis of proteins, specifically the Complex I protein from bovine mitochondria. Richard then trained to be a secondary school science teacher and worked for five years in Cambridgeshire, before returning to research at the University of Cambridge Division of Neurosurgery, where he used HPLC and other techniques to measure the levels of amino acids and neurotransmitters in brain extracellular fluid from neurotrauma patients at Addenbrookes Hospital. In 2014, Richard returned to the pharmaceutical industry, taking a position at MedImmune, the Biologics unit of AstraZeneca, where he has worked in the Analytical Sciences group on a range of projects including mAbs, peptides, bi-specifics, ADCs and mRNA.